Skip to main content

Read the latest news about Alfa Study, the research platform at the Barcelonaβeta Brain Research Center (BBRC) to identify early pathophysicological characteristics of Alzheimer's disease to develop prevention strategies.

15 Jul | 2021

"A titanic effort is being made to understand Alzheimer's disease in its early stages"

Interview with Gemma Salvadó, researcher of the Neuroimaging Group, after obtaining her PhD

13 Jul | 2021

Identified a new association between light neurofilaments and other markers of Alzheimer's disease

Researchers at the Barcelonaβeta Brain Research Center (BBRC) have identified that people with amyloid pathology and subjective cognitive impairment have an increase in light neurofilaments (NfL) in the cerebrospinal fluid and a lower volume in the hippocampus.

08 Jul | 2021

Discover BBRC’s participation in the Alzheimer’s Association International Conference (AAIC 2021)

The team of the research center of the Pasqual Maragall Foundation presents 6 oral communications and 15 posters, and participates in about fifteen international collaborations

16 Jun | 2021

Weight loss may be an indicator of an increased risk of developing Alzheimer's disease

A study led by the BBRC, with the support of the “la Caixa” Foundation, suggests that people at increased risk of developing Alzheimer's experience weight loss that would precede cognitive impairment.

19 Mar | 2021

The Alfa Study is already reaping the first fruits for an Alzheimer's-free future

The BBRC and the Pasqual Maragall Foundation publish an animated video to thank the effort of the participants, and of all the people and entities that support the research

06 Apr | 2021

BBRC researchers discovered new benefits of blue fish consumption in people at risk of developing Alzheimer's disease

A study led by the BBRC has found that people without cognitive problems but with a higher genetic risk of developing Alzheimer's have certain areas of the brain more resilient to the disease if they are accustomed to consuming a nutrient provided by blue fish.

11 Mar | 2021

European researchers improve the sensitivity to detect the early stages of Alzheimer's disease

A team of researchers from the AMYPAD consortium, led at BBRC, showed that the visual assessment used in clinical practice to evaluate amyloid PET images is sensitive to detecting the earliest stages of Alzheimer’s disease, and suggests a method to classify the extent of the pathology in the brain.

05 Feb | 2021

Visits to the new study on the relationship between insomnia and Alzheimer's begin

200 participants from the Alfa + study will participate in Alfa Sleep

10 Nov | 2020

BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease

An international team of researchers, led at the BBRC, has discovered that a series of biomarkers recently described to detect the most advanced phase of Alzheimer's can also detect the preclinical phase of the disease in the cerebrospinal fluid and plasma.